Skip to main content
Clinical Trials/NCT05208346
NCT05208346CompletedNot Applicable

Acute Effects of Canola Oil Compared With Coconut Oil on Postprandial Metabolism in Women and Men With Increased Risk for Cardiometabolic Diseases

University of Bonn2 sites in 1 country30 target enrollmentStarted: March 9, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
2
Primary Endpoint
Parameters of lipid metabolism in blood I

Study Overview

Brief Summary

The aim of this study is to investigate the postprandial effects of fat content and fatty acid composition of mixed meals on parameters associated with cardiometabolic diseases. Therefore, older subjects with increased risk of cardiometabolic diseases consume 4 mixed meals with 25 or 50 g of either canola or coconut oil. In a postprandial period of 6 hours, outcomes associated with cardiometabolic risk (e.g., triglycerides) are analyzed.

Detailed Description

In a crossover design, 30 older men and women with increased risk of cardiometabolic diseases consume 4 mixed meals, enriched with either 25 or 50 g canola or coconut oil. During a postprandial period of 6 hours, parameters of lipid metabolism (e.g., plasma triglycerides), glucose metabolism (e.g., plasma glucose, serum insulin), as well as markers of inflammation (e.g., IL-6), vascular system (e.g., pulse wave velocity) and antioxidant system (e.g., trolox equivalent antioxidative capacity) are analyzed. Furthermore, fatty acid profile, neuropsychologic parameters (e.g., attention), subjective feeling of hunger and satiety, and satiety-associated hormones (e.g., ghrelin) are assessed. Each intervention arm will be separated by a washout period of about 14 days.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Single (Participant)

Eligibility Criteria

Ages
60 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • BMI: 27 - 34,9 kg/m2
  • Waist circumference: women ≥ 80 cm, men ≥ 94 cm
  • At least two of the following criteria of metabolic syndrome:
  • Fasting triglycerides in serum: ≥ 150 mg/dl Fasting HDL-Cholesterol in serum: women < 50 mg/dl, men < 40 mg/dl Systolic blood pressure: ≥ 130 mmHg, diastolic blood pressure: ≥ 85 mmHg Fasting glucose in plasma: ≥ 100 mg/dL

Exclusion Criteria

  • Diseases that may impact outcome measures (e.g., thyroid diseases, insulin-dependent diabetes mellitus, impaired renal function, tumors, anemia)
  • Intake of immunosuppressives or supplements (e.g., fish oil)
  • Participation in another study

Outcomes

Primary Outcomes

Parameters of lipid metabolism in blood I

Time Frame: Postprandial period of 6 hours

Measurement of triglycerides (mg/dl)

Parameters of lipid metabolism in blood II

Time Frame: Postprandial period of 6 hours

Measurement of total cholesterol (mg/dl)

Parameters of lipid metabolism in blood VI

Time Frame: Postprandial period of 6 hours

Measurement of free fatty acids (mmol/L)

Parameters of lipid metabolism in blood III

Time Frame: Postprandial period of 6 hours

Measurement of LDL cholesterol (mg/dl)

Parameters of lipid metabolism in blood IV

Time Frame: Postprandial period of 6 hours

Measurement of HDL cholesterol (mg/dl)

Parameters of glucose metabolism in blood I

Time Frame: Postprandial period of 6 hours

Measurement of glucose (mg/dl)

Parameters of glucose metabolism in blood II

Time Frame: Postprandial period of 6 hours

Measurement of insulin (nmol/L)

Secondary Outcomes

  • Assessment of hunger and satiety(Postprandial period of 6 hours)
  • Assessment of gut hormones(Postprandial period of 6 hours)
  • Assessment of attention and memory(Postprandial period of 6 hours)
  • Postprandial endothelial function(Postprandial period of 6 hours)
  • Postprandial inflammation(Postprandial period of 6 hours)
  • Antioxidant system(Postprandial period of 6 hours)
  • Fatty acid profile(Postprandial period of 6 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. Sarah Egert

Prof. Dr. Sarah Egert

University of Bonn

Study Sites (2)

Loading locations...

Similar Trials